Moonshots with Peter Diamandis EP #17 David Sinclair’s AMA: Age Reversal Breakthroughs, FDA Approval, and Living Forever
Dec 22, 2022
David Sinclair, a leading biologist and professor at Harvard, dives into exciting breakthroughs in age-reversal and the complexities of FDA approvals. He shares his insights on the viability of living longer, discussing promising drugs and the ambitious Age Reversal XPRIZE initiative. Sinclair reflects on the intersection of happiness, responsibility, and the demands of groundbreaking research, emphasizing resilience in both personal life and the quest for longevity. Tune in for a glimpse into the science of extending life and the future of anti-aging treatments!
AI Snips
Chapters
Books
Transcript
Episode notes
Current Anti-Aging Drugs
- Some existing drugs like metformin and rapamycin may slow aging.
- These are not widely accessible yet because most doctors are unaware of this use.
Drug Development Challenges
- Developing new anti-aging drugs is challenging and expensive, often costing millions.
- Safety and efficacy testing by the FDA contributes to a lengthy process.
FDA's Cautious Approach
- The FDA prioritizes safety, valuing lives lost from drug approval errors over lives lost from delayed approvals.
- This cautious approach slows down the approval of anti-aging therapies.
